|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 109, Issue 6 1393-1403, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
S Leppa, K Vleminckx, F Van Roy and M Jalkanen
Department of Medical Biochemistry, University of Turku, Finland.
E-cadherin is a Ca(2+)-dependent cell-cell adhesion molecule, which is mainly expressed in epithelial cells. Recent studies have shown that E-cadherin has an important role as an invasion suppressor molecule in epithelial tumor cells. Syndecan-1 is a cell surface proteoglycan that has been implicated in a number of cellular functions including cell-cell adhesion, cell-matrix anchorage and growth factor presentation for signalling receptors. Its suppression has also been shown to be associated with malignant transformation of epithelial cells. In order to better understand the coordinated regulation of cell-cell and cell-matrix interactions during malignant transformation, we have studied the expression of syndecan-1 in malignant mammary tumor cells genetically manipulated for E-cadherin expression. In invasive NM-e-ras-MAC1 cells, where E-cadherin was partially downregulated by specific antisense RNA, syndecan-1 expression was suppressed. Furthermore, transfection of E-cadherin cDNA into invasive NM-f-ras-TD cells resulted in the upregulation of syndecan-1 expression in association with decreased invasiveness. In both cases, regulation of syndecan-1 occurred post-transcriptionally, since syndecan-1 mRNA levels remained unchanged. Instead, a translational regulation is suggested, since syndecan-1 core protein synthesis was E-cadherin dependent. Another cell adhesion protein, beta 1-integrin was not affected by E-cadherin expression. The data provide an example of coordinated changes in the expression of two cell adhesion molecules, syndecan-1 and E-cadherin during epithelial cell transformation.
This article has been cited by other articles:
|
|
 |
|
  A. Orosco, O. Fromigue, C. Bazille, N. Entz-Werle, P. Levillain, P. J. Marie, and D. Modrowski Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma Cancer Res., April 15, 2007; 67(8): 3708 - 3715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Zimmermann, D. Tomatis, M. Rosas, J. Grootjans, I. Leenaerts, G. Degeest, G. Reekmans, C. Coomans, and G. David Characterization of Syntenin, a Syndecan-binding PDZ Protein, as a Component of Cell Adhesion Sites and Microfilaments Mol. Biol. Cell, February 1, 2001; 12(2): 339 - 350. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Lauer, A. Volkl, S. Riedl, H. D. Fahimi, and K. Beier Impairment of peroxisomal biogenesis in human colon carcinoma Carcinogenesis, June 1, 1999; 20(6): 985 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Longley, A Woods, A Fleetwood, G. Cowling, J. Gallagher, and J. Couchman Control of morphology, cytoskeleton and migration by syndecan-4 J. Cell Sci., January 10, 1999; 112(20): 3421 - 3431. [Abstract] [PDF]
|
|
|
|
 |
|
 A. E. Aplin, A. Howe, S. K. Alahari, and R. L. Juliano Signal Transduction and Signal Modulation by Cell Adhesion Receptors: The Role of Integrins, Cadherins, Immunoglobulin-Cell Adhesion Molecules, and Selectins Pharmacol. Rev., June 1, 1998; 50(2): 197 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Woods and J. R. Couchman Integrin Modulation by Lateral Association J. Biol. Chem., August 4, 2000; 275(32): 24233 - 24236. [Full Text] [PDF]
|
|
